GPX4 and cancer: This form of cell death was identified in cancer cells in 2012 when it was shown that erastin, a small anti-cancer molecule, depleted intracellular glutathione (GSH), inactivated glutathione peroxidase 4 (GPX4; inhibitor of lipid peroxidation), and triggered iron-dependent cell death in a non-apoptotic manner [50–52].